Drug Safety Alert PVPI November 2023

Dear Pharma Aspirants,

Drug Safety Alert PVPI November 2023 – Monthly Drug Safety Alert

Healthcare Professionals, Patients/Consumers are advised to closely monitor the possibility
of the above ADR associated with the use of above suspected drug. If, such reaction is
encountered, please report to the NCC-PvPI, IPC by filling of Suspected Adverse Drug
Reactions Reporting Form/Medicines Side Effect Reporting Form for Consumer
(http://www.ipc.gov.in), through Android Mobile App “ADR PvPI” and PvPI Helpline No.

Suspected Drug : Mefenamic Acid

Indication: Treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhoea, mild to moderate pain, inflammation, fever, dental pain.
Adverse Drug Reaction: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

ALSO READ: New Label Warning for FDC of Chlorpheniramine Maleate

For More Updates Join our group: Click Here

Share It

About the Author: Kiran Kumar Chemudugunta

Kiran Kumar Chemudugunta with 15 Plus years of Experience in IT Life Sciences Industry, My Expertise in Pharmacovigilance and Computer System Validation. I have worked with Multinational Companies like TechMahindra Bioclinica Cognizant Icon Clinical Research Hcl Technologies Founder of Pvchronicle, Rise Trainings & Recruiting Best

You might like

Leave a Reply

Your email address will not be published. Required fields are marked *